Intco Medical Technology Co., Ltd. (SHE:300677)
China
· Delayed Price · Currency is CNY 24.18
-0.53 (-2.14%)
Apr 3, 2025, 3:04 PM CST
Intco Medical Technology Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
Net Income | 739.61 | 383 | 629.07 | 7,430 | 7,007 | 178.32 | Upgrade
|
Depreciation & Amortization | 718.92 | 718.92 | 629.94 | 368.62 | 140.02 | 92.21 | Upgrade
|
Other Amortization | 4.61 | 4.61 | 1.14 | 0.15 | 0.59 | 0.29 | Upgrade
|
Loss (Gain) From Sale of Assets | -0.21 | -0.21 | -2.37 | -0.38 | -0.02 | 0.05 | Upgrade
|
Asset Writedown & Restructuring Costs | 51.03 | 51.03 | 37.53 | 93.05 | 15.57 | 0.43 | Upgrade
|
Loss (Gain) From Sale of Investments | -263.01 | -263.01 | -151.91 | -61.12 | -4.71 | -2.28 | Upgrade
|
Provision & Write-off of Bad Debts | - | - | - | - | - | 0.79 | Upgrade
|
Other Operating Activities | -56.67 | 26.83 | -198.22 | 96.04 | 300.8 | 30.5 | Upgrade
|
Change in Accounts Receivable | -606.63 | -606.63 | 195.71 | 185.55 | -901.6 | -79.15 | Upgrade
|
Change in Inventory | -151.44 | -151.44 | 55.29 | -240.93 | -615.62 | -26.5 | Upgrade
|
Change in Accounts Payable | 430.85 | 430.85 | -190.87 | -314.25 | 1,812 | 115.63 | Upgrade
|
Change in Other Net Operating Assets | 8.15 | 8.15 | 6.01 | 43.38 | 49.84 | 6.57 | Upgrade
|
Operating Cash Flow | 775.52 | 502.41 | 1,065 | 8,680 | 8,590 | 329.69 | Upgrade
|
Operating Cash Flow Growth | - | -52.85% | -87.72% | 1.04% | 2505.63% | 77.46% | Upgrade
|
Capital Expenditures | -1,886 | -1,439 | -1,715 | -5,444 | -2,900 | -536.57 | Upgrade
|
Sale of Property, Plant & Equipment | 12.98 | 16.81 | 67.28 | 5.58 | 0.18 | 0.06 | Upgrade
|
Divestitures | - | - | - | 4.6 | - | - | Upgrade
|
Investment in Securities | -2,322 | -2,638 | -297.13 | -2,325 | -1,124 | -265.7 | Upgrade
|
Other Investing Activities | 153.9 | 83.86 | 78.45 | 28.48 | 12.63 | 11.11 | Upgrade
|
Investing Cash Flow | -4,041 | -3,976 | -1,867 | -7,730 | -4,015 | -791.1 | Upgrade
|
Long-Term Debt Issued | - | 7,896 | 1,849 | 560.29 | 418.42 | 2,119 | Upgrade
|
Long-Term Debt Repaid | - | -2,312 | -563.75 | -438.03 | -839.97 | -1,895 | Upgrade
|
Net Debt Issued (Repaid) | 8,178 | 5,583 | 1,286 | 122.26 | -421.56 | 224.36 | Upgrade
|
Issuance of Common Stock | - | - | 66.45 | - | 556.28 | 17.08 | Upgrade
|
Repurchase of Common Stock | -5 | - | - | -1.41 | - | - | Upgrade
|
Common Dividends Paid | -279.46 | -184.92 | -457.11 | -1,074 | -162.8 | -55.04 | Upgrade
|
Other Financing Activities | -5,865 | -2,389 | -346.04 | 119.95 | 84.22 | 287.8 | Upgrade
|
Financing Cash Flow | 2,029 | 3,009 | 549.05 | -833.25 | 56.14 | 474.2 | Upgrade
|
Foreign Exchange Rate Adjustments | -234.92 | 67.05 | 271.8 | -41.77 | -292.11 | 3.38 | Upgrade
|
Net Cash Flow | -1,471 | -397.43 | 19.69 | 74.8 | 4,340 | 16.18 | Upgrade
|
Free Cash Flow | -1,110 | -936.28 | -649.76 | 3,236 | 5,690 | -206.88 | Upgrade
|
Free Cash Flow Growth | - | - | - | -43.12% | - | - | Upgrade
|
Free Cash Flow Margin | -12.37% | -13.53% | -9.82% | 19.93% | 41.12% | -9.93% | Upgrade
|
Free Cash Flow Per Share | -1.70 | -1.42 | -0.98 | 4.79 | 9.18 | -0.38 | Upgrade
|
Cash Income Tax Paid | - | -327.53 | -729.81 | -335.24 | 108.07 | -99.7 | Upgrade
|
Levered Free Cash Flow | -330.72 | -1,447 | -994.12 | -230.09 | 2,854 | -323.29 | Upgrade
|
Unlevered Free Cash Flow | -173.03 | -1,367 | -976.33 | -219.09 | 3,019 | -305.75 | Upgrade
|
Change in Net Working Capital | -600.52 | 555.45 | -151.84 | 548.19 | -343.32 | 3.72 | Upgrade
|
Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.